Illustrative image.
Rexulti
Brexpiprazole
$384.00
1mg · 3 × 28 tablets · 3 months supply
BrandBranded medicine· By Lundbeck
$128.00 per month
Strength
How long a supply?
Test mode: no payment is taken. View cart
Annual cost
$1664a year at this pack size
Prescription required
Upload your prescription after ordering, or send it to our pharmacy team. We dispense only against a valid prescription.
0.5mg
1mg
2mg
3mg
4mg
FDA boxed warningIncreased mortality in elderly patients with dementia-related psychosis and suicidal thoughts and behaviors
Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at increased risk of death. REXULTI is not approved for the treatment of patients with dementia-related psychosis without agitation associated with dementia due to Alzheimer's disease.
Antidepressants increased the risk of suicidal thoughts and behaviors in pediatric and young adult patients. Closely monitor all antidepressant-treated patients for clinical worsening and emergence of suicidal thoughts and behaviors. Safety and effectiveness of REXULTI have not been established in pediatric patients with MDD.
About Rexulti
Overview
Rexulti tablets contain brexpiprazole, an atypical antipsychotic medicine. It is used alongside antidepressants to treat major depressive disorder in adults. It also treats schizophrenia in adults and children aged 13 years and older. Rexulti is also used to treat agitation associated with dementia due to Alzheimer’s disease, but not as an “as-needed” treatment.
What it treats
- Major depressive disorder in adults, used alongside an antidepressant. - Schizophrenia in adults and children aged 13 years and older. - Agitation associated with dementia due to Alzheimer’s disease. Rexulti is not indicated for as-needed treatment of this agitation.
Safety information
Side effects
Common side effects vary by the condition being treated: - In adults taking Rexulti with an antidepressant for major depressive disorder: weight gain, sleepiness and akathisia (a feeling of restlessness or a need to keep moving). - In adults with schizophrenia: weight gain. - In adolescents aged 13–17 with schizophrenia: movement-related side effects. - In adults with agitation associated with dementia due to Alzheimer’s disease: inflammation of the nose and throat, and dizziness. Serious risks include suicidal thoughts and behaviours in adolescents and young adults, and an increased risk of death and stroke in elderly patients with dementia-related psychosis. Seek immediate medical help for suicidal thoughts or behaviours, a suspected stroke, seizures, or suspected neuroleptic malignant syndrome, a serious reaction listed in the label. Contact a doctor promptly about involuntary movements, new or increased gambling or other compulsive behaviours, fainting, falls, difficulty swallowing, or problems regulating body temperature. Rexulti can also impair thinking and movement; use caution when operating machinery. Other serious effects include high blood sugar or diabetes, changes in blood fats, weight gain and low white blood cell counts. Monitoring is needed for blood sugar, blood fats and weight. Blood counts should be checked in people with an existing low white blood cell count or a history of low white blood cells. Blood pressure and heart rate may also need monitoring because Rexulti can cause a drop in blood pressure on standing and fainting.
FDA boxed warning
Increased mortality in elderly patients with dementia-related psychosis and suicidal thoughts and behaviors
Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at increased risk of death. REXULTI is not approved for the treatment of patients with dementia-related psychosis without agitation associated with dementia due to Alzheimer's disease.
Antidepressants increased the risk of suicidal thoughts and behaviors in pediatric and young adult patients. Closely monitor all antidepressant-treated patients for clinical worsening and emergence of suicidal thoughts and behaviors. Safety and effectiveness of REXULTI have not been established in pediatric patients with MDD.
A boxed warning is the strongest warning the US Food and Drug Administration requires on a medicine label. Text is taken from the official label, with internal section references removed.
When to call your doctor
If symptoms are severe or getting worse quickly, seek emergency care rather than waiting.
Before taking this medicine
Do not take Rexulti if you have a known allergy to brexpiprazole or any of its ingredients. Allergic reactions have included rash, hives, facial swelling and anaphylaxis, a severe allergic reaction. Conditions requiring caution or monitoring include: • Dementia-related psychosis in older adults, because of an increased risk of stroke or transient ischaemic attack (TIA). • Diabetes or high blood sugar, abnormal blood fats, or weight gain. These should be monitored during treatment. • A low white blood cell count or a history of low white blood cells. Blood count monitoring may be needed. • Heart or blood vessel disease, dehydration, or a risk of fainting. Rexulti can cause a fall in blood pressure on standing; heart rate and blood pressure may need monitoring. • A history of seizures or conditions that increase seizure risk. • Pregnancy, particularly exposure during the third trimester, which may cause movement-related or withdrawal symptoms in the newborn. Other important risks include neuroleptic malignant syndrome, tardive dyskinesia (involuntary movements), and compulsive behaviours such as pathological gambling. These may require the prescriber to stop treatment. Use caution when operating machinery because Rexulti may impair thinking and movement.
Interactions
Tell your doctor about all medicines you take. Medicines that strongly block the enzymes CYP2D6 or CYP3A4 can require an adjustment to your Rexulti prescription. Taking medicines that block both enzymes may also require an adjustment, as may taking a CYP3A4 blocker if your body breaks down medicines slowly through CYP2D6. Paroxetine and fluoxetine are examples of strong CYP2D6 blockers. The label notes that no adjustment is needed for these medicines when Rexulti is used for major depressive disorder. Medicines that strongly increase CYP3A4 activity can also require an adjustment. Your prescriber should manage any changes; do not change your dose yourself.
Using Rexulti
Dosing
Dosing is set by your prescriber. Each health care professional may prescribe medication differently according to a patient's medical history and condition, so follow the directions on your prescription label and speak to your doctor or pharmacist before changing anything.
Storage
Store below 25°C in a dry place, in the original pack, away from direct light and moisture. Do not keep it in a bathroom. Keep all medicines out of the sight and reach of children.
Clinical information on this page is summarised from the US FDA label REXULTI (BREXPIPRAZOLE) TABLET [REMEDYREPACK INC.] (DailyMed, retrieved 19 September 2026).
Reviews
No reviews yet. Mail Order Drugs opened recently, and we publish reviews only from verified customers of this site, so this space stays empty until real ones arrive.
- Every prescription order is checked by a licensed pharmacist before dispensing.
- Payment pages are encrypted and card details never reach our servers.
- We ship internationally, with cold-chain packing where a medicine needs it.
Related medicines
Modal
Sulpiride
Tablets · from 30 per pack
Also for antipsychotics
Generic from $20.00
Loxitane
Loxapine
Also for antipsychotics
Pack sizes and pricing not listed yet
Fanapt
Iloperidone
By Patheon
Tablets · from 8 per pack
Also for antipsychotics
Brand from $20.00
Solian
Amisulpride
By UniPharm
Tablets · from 30 per pack
Also for antipsychotics
Generic from $31.00